Edinburgh Drug Discovery

Asier Unciti-Broceta (Manager),
Scott Webster (Manager) &
Neil Carragher (Manager)

School of Genetics and Cancer

Facility/equipment: Facility

Details

Name	ImageXpress Confocal HT.ai
Manufacturers	Molecular Devices

Name	ImageXpress Widefield
Manufacturers	Molecular Devices

Name	Incucyte S3 and S5
Manufacturers	Sartorius AG

Contact information

Name	Asier Unciti-Broceta

99 Article
3 Review article
2 Meeting abstract
2 Editorial
More
- 2 Preprint

High-throughput 3D phenotypic screening identifies repurposed MEK inhibitors as drivers of chondrogenesis for cartilage regeneration
Hajiali, H., Cholewa-Waclaw, J., Ballard, J., Okur, K. E., Elliott, R., Carragher, N. O. & El Haj, A. J., 23 Feb 2026, (E-pub ahead of print) In: Frontiers in Bioengineering and Biotechnology. 14
Research output: Contribution to journal › Article › peer-review

Open Access
File
Abstract PS4-06-07: Yes/src kinase inhibitor nxp900, currently in clinical development, combines synergistically with fulvestrant against luminal a breast cancer cell lines in vitro and in vivo
Lanzagorta-Calvillo, I., Kaghazchi, B., Poradosu, E., Carragher, N. O. & Unciti-Broceta, A., 17 Feb 2026, In: Clinical Cancer Research. 32, 4_Supplement, p. PS4-06-07-PS4-06-07
Research output: Contribution to journal › Article › peer-review
High throughput screening identifies activity of histone deacetylase inhibitors in patient-derived models of soft tissue sarcoma
Danks, M., Manasterski, P., Beetham, H., Dawson, J. C., Elliott, R., Culley, J., Krishna, R., Muir, M. T., Thomson, J. P., Oswald, A., Ewing, A., Kerrison, W. G. J., Huang, P. H., Nixon, I., Carragher, N. O. & Brunton, V. G., 31 Dec 2025, In: Cancer Biology & Therapy. 26, 1, 2589666.
Research output: Contribution to journal › Article › peer-review

Open Access
File